Consensus Oncodesign Precision Medicine

Equities

Market Closed - Euronext Paris Other stock markets 11:28:51 2024-05-30 am EDT			5-day change	1st Jan Change
1.29 ^EUR	0.00%		+3.61%	-28.73%

May. 15	Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents	CI
Jan. 25	Oncodesign Precision Medicine: fundraising on the horizon	CF

f113d5.5VGpXdDqN0aIDTyF6OnVJsUq0ZJ-9HHJ0md8hvOLteY.yBf2ZOinRgDMWEvUqraKT4QTlas4miainDZF7aXAz9eiBuEHt5BQJcRLVw~a9e4996913c62191c14a704c84b130e5

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.29 EUR

Average target price

2.48 EUR

Spread / Average Target

+92.25%

High Price Target

2.66 EUR

Spread / Highest target

+106.20%

Low Price Target

2.3 EUR

Spread / Lowest Target

+78.29%

Trading Rating

Investor Rating

ESG Refinitiv